semaglutide side effects reviews consumer reports Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide Side Effects: What Patients
Description
Research Highlights: Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality
Recommended for daily health management
95% confidence interval [CI]0.8,0.6) were sustained at 12 months
Listen along with enhanced, synced transcriptions and more.
Encourage people living with obesity to engage with weight management programmes
